Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRLS - Chrysalis : Any followers ? Any comments ? -- Ignore unavailable to you. Want to Upgrade?

To: Mr Bond who wrote (47)	5/17/1998 9:51:00 PM
From: Steve Lokness	Read Replies (1) \| Respond to of 51

Mr Bond; Very interesting post - thanks. You obviously know the CRO business a lot better than I do. At what price would you feel comfortable about picking up more CRLS? While I have a position it is small and I would like to pick up considerable more. I was already wondering if 1 5/8 or so was a great chance and yet if earnings continue to be depressed for awhile as you mentioned, there might be more opportunities. I agree that AXPH will not likely be a buyer, only that it looks like it would make sense to me from a business standpoint. But maybe another biotech like AXPH - I don't follow very many of them. The VC idea is very intriging and an angle I had not thought of. I suppose if it was up to us we would buy CRLS and give it a little juice. In any case the CRO business must have a great near term future with the huge numbers of products entering trials. Any way I look at CRLS it is hard to imagine them not having a great future. Steve